The initial success of recombinant human bone morphogenetic proteins (rhBMPs) in lumbar spine surgery led to its use outside the initial indication. As complications from the use of rhBMP-2 in cervical spine surgery continued to rise, the need for a safer alternative was evident. The discovery of a new allogeneic tissue processing technique has provided a way to access growth factors naturally found within bone marrow cells. This evaluation was undertaken to assess the clinical outcomes associated with the use of allogeneic morphogenetic protein in cervical spine fusion.High fusion rate results in this report demonstrate the benefits of using an array of growth factors in cervical spine surgery and support allogeneic morphogenetic protein as a possible alternative option to rhBMP-2.
Citation: Field J, Yeung C, Roh J (2014) Clinical Evaluation of Allogeneic Growth Factor in Cervical Spine Fusion. J Spine 3:158